| 1 |
32245188 | A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy. | 2020 Mar 21 |
2 |
| 2 |
30778749 | CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy. | 2019 May |
1 |
| 3 |
26574168 | Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma. | 2016 Mar |
1 |
| 4 |
20099300 | Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. | 2010 Apr |
4 |